SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-027422
Filing Date
2012-05-10
Accepted
2012-05-10 10:43:23
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v310737_10q.htm 10-Q 260886
2 EXHIBIT 31.1 v310737_ex31-1.htm EX-31.1 8963
3 EXHIBIT 31.2 v310737_ex31-2.htm EX-31.2 8909
4 EXHIBIT 32.1 v310737_ex32-1.htm EX-32.1 4923
5 EXHIBIT 32.2 v310737_ex32-2.htm EX-32.2 5079
  Complete submission text file 0001144204-12-027422.txt   1366090

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pip-20120331.xml EX-101.INS 106983
7 XBRL TAXONOMY EXTENSION SCHEMA pip-20120331.xsd EX-101.SCH 10446
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pip-20120331_cal.xml EX-101.CAL 34379
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pip-20120331_def.xml EX-101.DEF 69905
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pip-20120331_lab.xml EX-101.LAB 101720
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pip-20120331_pre.xml EX-101.PRE 82795
Mailing Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401
Business Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401 410 269 2600
PHARMATHENE, INC (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32587 | Film No.: 12828262
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences